Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115786313A reveals a novel nitrilase mutant boosting 2-chloronicotinic acid yield by 23.2 times, offering a green alternative for pharma and agrochemical intermediates.
Patent CN109369631B details a novel enzymatic route for LDHA inhibitor intermediates, offering high ee values and scalable manufacturing for reliable pharmaceutical suppliers.
Patent CN104630241A enables high-purity statin intermediate production with reduced waste and enhanced supply chain reliability for global pharmaceutical manufacturing partners seeking cost efficiency.
Patent CN100567236C details a green synthesis for Antioxidant 330 using ionic liquids, offering high purity and simplified workup for polymer additive supply chains.
Patent CN112625086A reveals a high-purity enzymatic route for Argatroban Impurity G. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN1074405C details a novel hydroformylation process for 1,3-propanediol intermediates, offering superior catalyst recycling and cost reduction in manufacturing.
Patent CN110511172A details loaded catalyst synthesis for bismaleimide. Ensures high purity and recyclable processes for reliable supply chain and cost efficiency.
Patent CN105503534A details resin-catalyzed synthesis. Eliminates wastewater, ensures high purity for UV absorber intermediates. Reliable supply chain partner.
Novel asymmetric [3+2] cyclization method for high-purity chiral five-membered thiaheterocyclic nucleoside analogues with superior enantioselectivity and scalable yield.
Patent CN103012440B reveals one-pot synthesis for thiazolo pyrimidine derivatives offering high yield and supply chain efficiency for pharmaceutical intermediates manufacturing.
Patent CN104803956A details a safer firocoxib synthesis. Eliminates column chromatography and hazardous reagents for scalable manufacturing.
Patent CN107384982A reveals enzymatic route for Evogliptin. Offers high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN111051506A discloses engineered PGA variants for efficient insulin dimer deprotection. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain advantages.
Patent CN109180496B details a novel lipase-catalyzed resolution and Mitsunobu reaction for Cinacalcet. Achieve high purity without hazardous reducing agents.
Novel mild synthesis route for 3,3-diethoxy-1-propanol via malonaldehyde. Reduces pressure risks and boosts purity for reliable pharmaceutical intermediate supply chains.
Patent CN101993318A details a mild AuCl3-catalyzed halogenation method. This report analyzes cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Novel chiral epoxy propyl benzo-heterocycle synthesis for ROMK inhibitors. High ee, scalable route for pharmaceutical intermediates supply.
Patent CN116621855B reveals a novel photocatalytic route for Rubescensine A derivatives, offering enhanced solubility and streamlined manufacturing for pharmaceutical intermediates.
Patent CN114702471A details a green air-oxidation method for caronic anhydride, replacing hazardous ozone processes to ensure reliable pharmaceutical intermediate supply.
Novel carbonyl reductase mutants enhance chiral alcohol synthesis yield and stability for pharmaceutical manufacturing supply chains ensuring reliable high-purity intermediate sourcing.